$COTY

Gucci Beauty License Shift to L’Oréal: Analysts Weigh Impact on Coty’s Future

Coty Inc. said it will end its Gucci Beauty fragrance and license early, with L’Oréal taking over a 50-year exclusive beauty license effective mid-2027. Coty will receive about $400 million in two payments ($250 million this year, up to $150 million in 2027). Analysts at Jefferies and Barclays weigh impacts on Coty’s EBITDA estimates and note the next update is due with Q4 earnings.

Original reporting
Published Jul 8, 2026, 10:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 8, 2026, 10:23 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Gucci Beauty License Shift to L’Oréal: Analysts Weigh Impact on Coty’s Future — source image
Decision brief

The 30-second read

$COTYNeutralMed
01

Why it matters

Coty gains $400 million for early redemption and avoids the later expiration uncertainty, but analysts estimate a meaningful FY28 adjusted EBITDA headwind and expect more clarity at the upcoming fourth-quarter earnings release.

02

Market read

The deal is a concrete portfolio and cash-flow event for Coty, with the market already partially reacting, while the earnings offset question remains unresolved.

03

What to watch

The article does not quantify how much of the lost Gucci EBITDA can be replaced by other franchises or cost actions, so the FY28 gap may be narrower than Barclays’ assumptions.

Relevance 7/10Novelty 6/10Timing: ahead of Coty’s next month fourth-quarter earnings release for more detail on the EBITDA gap.

Background

Gucci Beauty’s fragrance and licensing arrangement with Coty was set to expire June 30, 2028, but L’Oréal entered a 50-year exclusive beauty license effective mid-2027.

Company-level read

Ticker impact

$COTYNeutralMedium confidence
Context

Coty will receive about $400 million for early redemption of the Gucci Beauty license, with payments split $250M this year and up to $150M in 2027.

Expected impact

Near-term sentiment likely supported by the resolved timeline and cash inflow, but downside risk remains if FY28 EBITDA gap from lost Gucci is not offset.

Evidence & confidence

The article cites both the positive framing (resolved litigation and earlier-than-scheduled exit) and quantified downside estimates (Barclays: FY28 sales -4% and adjusted EBITDA -32%, plus ~$115M adjusted EBITDA hit from Gucci).

Market effects

Prestige fragrance licensing dynamics may shift as major brands reallocate franchise economics and litigation risk.

Middle East escalation is cited as a modest headwind to Coty like-for-like sales in the latest quarter.

Signals ongoing restructuring of beauty fragrance portfolios among large brand owners and license holders.

Counterpoint

The upfront cash and earlier resolution could be more than offset by faster debt reduction and reallocation into higher-return core brands, limiting the practical EBITDA drag.

Key entities

  • Coty Inc.

    Receives upfront cash for early redemption of the Gucci Beauty license and faces an estimated FY28 EBITDA gap risk.

  • L’Oréal

    Takes over a 50-year exclusive beauty license for Gucci Beauty effective mid-2027.

  • Jefferies (Sydney Wagner)

    Views the transaction as more favorable than a standard 2028 expiration due to cash and litigation resolution.

  • Barclays (Lauren Lieberman)

    Estimates FY28 sales and adjusted EBITDA declines and highlights the challenge of filling the lost EBITDA gap.

Related articles

$COTYMed

Analysis-No Gucci, no problem? Coty learns to live without flagship brand By Reuters

Reuters reports Coty will exit its Gucci Beauty licence a year early under a $400 million deal, returning the licence to Kering in mid-2027. Coty estimates it will forgo about $115 million annual adjusted EBITDA (15%), but expects $250 million upfront plus $150 million later to cut net debt (~$2.9B) and reduce costs. Barclays and analysts cite margin pressure but less Gucci dependence.

$COTYMedAI 8/10

Luxury retailer exits beauty business and ends major partnership

Kering (PPRUY) said Gucci and L’Oréal (LRLCY) will start a 50-year exclusive beauty licensing deal in mid-2027, replacing Gucci’s current Coty (COTY) license that was set to run until June 30, 2028. Coty will receive about $400 million for early termination. Kering expects proceeds to support deleveraging after weaker performance, with net debt €9.5 billion at end-June 2025.

$COTYMedAI 8/10

Coty exits Gucci license early

Coty agreed to return the Gucci Beauty license to Kering about a year early for about $400 million, ending its current contract. Coty will use most proceeds to pay down debt and invest in brands like BOSS and Marc Jacobs. Deal terms include $250 million upfront, $150 million by Sept. 30, 2027, and up to $30 million incentives. Coty continues operating Gucci Beauty through June 30, 2027.

$COTYMed

Gucci and L'Oréal conclude a 50-year beauty licensing agreement

Kering said Gucci’s beauty licensing deal with Coty ends early, with Coty paying about $400 million. Kering will receive payments in 2026 ($250 million) and 2027 (up to $150 million). L’Oréal’s new Gucci beauty license is expected to start mid-2027, following a 2025 framework for L’Oréal to buy Kering’s beauty division for 4 billion euros.

$COTYMedAI 8/10

Coty Announces Agreement With Kering for Early Transition of Gucci Beauty License

Coty (NYSE: COTY) said it agreed with Kering to transition the Gucci Beauty license back to Kering about a year early. Coty will receive about $400 million, including $250 million at signing and $150 million by Sept. 30, 2027, plus a sale of inventory for the transition. Coty will run Gucci Beauty through at least June 30, 2027; proceeds will support debt paydown and reinvestment.